• Eurofins TRACĀ® Test for Monitoring Kidney Transplant Health
  • Metanephrines, Urine
  • Androgen Receptor (AR) Gene Mutation Analysis
  • Aortic Dysfunction or Dilation (eg, Marfan syndrome, Loeys Dietz syndrome, Ehler Danlos syndrome type IV, arterial tortuosity syndrome) Gene Mutation Panel, NGS
  • B-cell Activating Factor Receptor (BAFF-R) Gene Mutation Analysis
  • Brucella Antibody, IgG and IgM
  • Albumin, Body Fluid
  • Thyrotropin Releasing Hormone (TRH)
  • Reducing Substance, Feces
  • MGMT (O-6-methylguanine-DNA methyltransferase) Methylation Detection
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /CEBPA (CCAAT enhancer binding protein alpha) Gene Mutation Analysis
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References

CEBPA (CCAAT enhancer binding protein alpha) Gene Mutation Analysis
Medical Test

Interpretation
Access to CEBPA (CCAAT enhancer binding protein alpha) Gene Mutation Analysis is restricted.